Showing results (91-100 of 99) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activityGuido Marcucci, Wendy Stock, Guowei Dai, et al.Blood|October 7, 2004
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaJohn C Byrd, Guido Marcucci, Mark R Parthun, et al.The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.Blood|May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemiaWilliam Blum, Sebastian Schwind, Somayeh S Tarighat, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoproteinCraig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, et al.Blood|October 24, 2002
Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemiaGuido Marcucci, John C Byrd, Guowei Dai, et al.Cancer Cell|November 17, 2012
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylationAnjali Mishra, Shujun Liu, Gregory H Sams, et al.Cancer Cell|April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemiaShujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.Pageof 10